Cargando…

Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation

Tau is a microtubule-associated protein, and the oligomeric and hyperphosphorylated forms of tau are increased significantly after neurotrauma and considered important factors in mediating cognitive dysfunction. Blockade of adenosine A(2A) receptors, either by caffeine or gene knockout (KO), allevia...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Z-A, Zhao, Y, Ning, Y-L, Yang, N, Peng, Y, Li, P, Chen, X-Y, Liu, D, Wang, H, Chen, X, Bai, W, Chen, J-F, Zhou, Y-G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534966/
https://www.ncbi.nlm.nih.gov/pubmed/28485728
http://dx.doi.org/10.1038/tp.2017.98
_version_ 1783253814163275776
author Zhao, Z-A
Zhao, Y
Ning, Y-L
Yang, N
Peng, Y
Li, P
Chen, X-Y
Liu, D
Wang, H
Chen, X
Bai, W
Chen, J-F
Zhou, Y-G
author_facet Zhao, Z-A
Zhao, Y
Ning, Y-L
Yang, N
Peng, Y
Li, P
Chen, X-Y
Liu, D
Wang, H
Chen, X
Bai, W
Chen, J-F
Zhou, Y-G
author_sort Zhao, Z-A
collection PubMed
description Tau is a microtubule-associated protein, and the oligomeric and hyperphosphorylated forms of tau are increased significantly after neurotrauma and considered important factors in mediating cognitive dysfunction. Blockade of adenosine A(2A) receptors, either by caffeine or gene knockout (KO), alleviates cognitive dysfunction after traumatic brain injury (TBI). We postulated that A(2A)R activation exacerbates cognitive impairment via promoting tau hyperphosphorylation. Using a mouse model of moderate controlled cortical impact, we showed that TBI induced hyperphosphorylated tau (p-tau) in the hippocampal dentate gyrus and spatial memory deficiency in the Morris water maze test at 7 days and 4 weeks after TBI. Importantly, pharmacological blockade (A(2A)R antagonist ZM241385 or non-selective adenosine receptor antagonist caffeine) or genetic inactivation of A(2A)Rs reduced the level of tau phosphorylation at Ser404 and alleviated spatial memory dysfunction. The A(2A)R control of p-tau is further supported by the observations that a KO of A(2A)R decreased the activity of the tau phosphorylation kinases, glycogen synthase kinase-3β (GSK-3β) and protein kinase A (PKA) after TBI, and by that CGS21680 (A(2A)R agonist) exacerbated okadaic acid-induced tau hyperphosphorylation in cultured primary hippocampal neurons. Lastly, CGS21680-induced neuronal tau hyperphosphorylation and axonal injury were effectively alleviated by individual treatments with ZM241385 (A(2A)R antagonist), H89 (PKA antagonist) and SB216763 (GSK-3β antagonist), or by the combined treatment with H89 and SB216763. Our findings suggest a novel mechanism whereby A(2A)R activation triggers cognitive dysfunction by increasing the phosphorylation level of tau protein after TBI and suggest a promising therapeutic and prophylactic strategy by targeting aberrant A(2A)R signaling via tau phosphorylation.
format Online
Article
Text
id pubmed-5534966
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-55349662017-08-01 Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation Zhao, Z-A Zhao, Y Ning, Y-L Yang, N Peng, Y Li, P Chen, X-Y Liu, D Wang, H Chen, X Bai, W Chen, J-F Zhou, Y-G Transl Psychiatry Original Article Tau is a microtubule-associated protein, and the oligomeric and hyperphosphorylated forms of tau are increased significantly after neurotrauma and considered important factors in mediating cognitive dysfunction. Blockade of adenosine A(2A) receptors, either by caffeine or gene knockout (KO), alleviates cognitive dysfunction after traumatic brain injury (TBI). We postulated that A(2A)R activation exacerbates cognitive impairment via promoting tau hyperphosphorylation. Using a mouse model of moderate controlled cortical impact, we showed that TBI induced hyperphosphorylated tau (p-tau) in the hippocampal dentate gyrus and spatial memory deficiency in the Morris water maze test at 7 days and 4 weeks after TBI. Importantly, pharmacological blockade (A(2A)R antagonist ZM241385 or non-selective adenosine receptor antagonist caffeine) or genetic inactivation of A(2A)Rs reduced the level of tau phosphorylation at Ser404 and alleviated spatial memory dysfunction. The A(2A)R control of p-tau is further supported by the observations that a KO of A(2A)R decreased the activity of the tau phosphorylation kinases, glycogen synthase kinase-3β (GSK-3β) and protein kinase A (PKA) after TBI, and by that CGS21680 (A(2A)R agonist) exacerbated okadaic acid-induced tau hyperphosphorylation in cultured primary hippocampal neurons. Lastly, CGS21680-induced neuronal tau hyperphosphorylation and axonal injury were effectively alleviated by individual treatments with ZM241385 (A(2A)R antagonist), H89 (PKA antagonist) and SB216763 (GSK-3β antagonist), or by the combined treatment with H89 and SB216763. Our findings suggest a novel mechanism whereby A(2A)R activation triggers cognitive dysfunction by increasing the phosphorylation level of tau protein after TBI and suggest a promising therapeutic and prophylactic strategy by targeting aberrant A(2A)R signaling via tau phosphorylation. Nature Publishing Group 2017-05 2017-05-09 /pmc/articles/PMC5534966/ /pubmed/28485728 http://dx.doi.org/10.1038/tp.2017.98 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Original Article
Zhao, Z-A
Zhao, Y
Ning, Y-L
Yang, N
Peng, Y
Li, P
Chen, X-Y
Liu, D
Wang, H
Chen, X
Bai, W
Chen, J-F
Zhou, Y-G
Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation
title Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation
title_full Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation
title_fullStr Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation
title_full_unstemmed Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation
title_short Adenosine A(2A) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation
title_sort adenosine a(2a) receptor inactivation alleviates early-onset cognitive dysfunction after traumatic brain injury involving an inhibition of tau hyperphosphorylation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534966/
https://www.ncbi.nlm.nih.gov/pubmed/28485728
http://dx.doi.org/10.1038/tp.2017.98
work_keys_str_mv AT zhaoza adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT zhaoy adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT ningyl adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT yangn adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT pengy adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT lip adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT chenxy adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT liud adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT wangh adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT chenx adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT baiw adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT chenjf adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation
AT zhouyg adenosinea2areceptorinactivationalleviatesearlyonsetcognitivedysfunctionaftertraumaticbraininjuryinvolvinganinhibitionoftauhyperphosphorylation